News Releases Items Per Page 102550 Year None2020201920182017201620152012 Nov 20, 2020 Galera Therapeutics to Participate in the Piper Sandler 32nd Annual Virtual Healthcare Conference View HTML PDF Version Nov 10, 2020 Galera Therapeutics Reports Third Quarter 2020 Financial Results and Provides Business Updates View HTML PDF Version Nov 03, 2020 Galera Therapeutics to Present at the 29th Annual Credit Suisse Virtual Healthcare Conference View HTML PDF Version Oct 27, 2020 Galera Therapeutics Announces Interim Data from Pilot Phase 1/2 Trial of GC4419 in Combination with Stereotactic Body Radiation Therapy Showed Improved Overall Survival in Patients with Locally Advanced Pancreatic Cancer View HTML PDF Version Oct 23, 2020 Galera Therapeutics Announces Positive Interim Data from First Cohort of Patients in Pilot Phase 1/2 Clinical Trial of GC4419 in Pancreatic Cancer View HTML PDF Version Oct 22, 2020 Galera Therapeutics Announces Dosing of First Patient in the Phase 1/2 GRECO-1 Clinical Trial of GC4711 in Combination with SBRT for Non-Small Cell Lung Cancer View HTML PDF Version Sep 22, 2020 Galera Therapeutics to Host Virtual KOL Event on the Treatment of Locally Advanced Pancreatic Cancer View HTML PDF Version Sep 16, 2020 Galera Therapeutics Announces Dosing of First Patient in a Randomized, Double-Blind Pilot Phase 2 Clinical Trial of GC4419 for COVID-19 View HTML PDF Version Sep 14, 2020 Galera Therapeutics to Present at the Oppenheimer Fall Healthcare Life Sciences & MedTech Summit View HTML PDF Version Sep 08, 2020 Galera Therapeutics Announces ASTRO Late-Breaker Presentation of Topline Safety and Efficacy Data from its Double-Blind, Placebo-Controlled Phase 1b/2a Clinical Trial of GC4419 in Combination with SBRT for Locally Advanced Pancreatic Cancer View HTML PDF Version Pagination Current page 1 Page 2 Page 3 Next page next › Last page last » Displaying 1 - 10 of 25 results